Evidence map›Paper›PMID 32397873›Full record

ArticleAutophagy2021

Involvement of CASP9 (caspase 9) in IGF2R/CI-MPR endosomal transport.

Jie Han, Leslie A Goldstein, Wen Hou, Simon C Watkins, Hannah Rabinowich

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Receptor Recycling by Retromer.Molecular and cellular biology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jie HanDepartments of Pathology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Leslie A GoldsteinDepartments of Pathology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Wen HouDepartments of Pathology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Simon C WatkinsCell Biology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Hannah RabinowichDepartments of Pathology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
UPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Sensitization of lung cancer to EGFR tyrosine kinase inhibitorsI01BX002307 · VA · VETERANS HEALTH ADMINISTRATION · PI RABINOWICH, HANNAH · 2015 to 2020
–
BLRD VA I01 BX002307NCI NIH HHS P30 CA047904
6 · The paper itself

Abstract

Recently, we reported that increased expression of CASP9 pro-domain, at the endosomal membrane in response to HSP90 inhibition, mediates a cell-protective effect that does not involve CASP9 apoptotic activity. We report here that a non-apoptotic activity of endosomal membrane CASP9 facilitates the retrograde transport of IGF2R/CI-MPR from the endosomes to the trans-Golgi network, indicating the involvement of CASP9 in endosomal sorting and lysosomal biogenesis. CASP9-deficient cells demonstrate the missorting of CTSD (cathepsin D) and other acid hydrolases, accumulation of late endosomes, and reduced degradation of bafilomycin A

Indexed as

AutophagyCaspase 9EndosomesHeLa CellsHumansMicrotubule-Associated ProteinsProtein TransportReceptor, IGF Type 2trans-Golgi NetworkVesicular Transport ProteinsCASP9 protein, humanCaspase 9IGF2R protein, humanMicrotubule-Associated ProteinsReceptor, IGF Type 2Vesicular Transport ProteinsCaspase-9endosomeHGS/HRS/ESCRT-0IGF2R/CI-MPRlysosomeretromer

Identifiers

PMID32397873
PMCPMC8204962
OpenAlexW3024511208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.